Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Nephrology · Autosomal Dominant Progressive Nephropathy

Building Your Care Team and Preparing for Appointments

At a Glance

For autosomal dominant progressive nephropathy, a coordinated care team can clarify the genetic diagnosis and plan kidney care. Prepare by bringing family history, imaging, creatinine and kidney-function trends, urine results, blood pressure logs, and prior biopsy or genetic reports.

Managing an inherited condition like autosomal dominant progressive nephropathy requires more than a single doctor. Because these diseases can affect your family, your heart, and your future transplant options, the best care often comes from a multidisciplinary team [1][2].

Building this team early—and arriving at your appointments prepared—is the most effective way to move from a general clinical label to a precise, personalized treatment plan [3].

Your Essential Care Team

While your needs may change over time, the following specialists form the core of an expert care team for inherited kidney disease:

  • Nephrologist (Kidney Specialist): This is your team leader. Ideally, you should seek a nephrologist who specializes in nephrogenetics or inherited diseases [1]. They understand the nuances of genetic variants and how they affect your kidney function differently than “standard” kidney disease [4].
  • Genetic Counselor: These professionals are essential for navigating the complex world of DNA testing [5]. They help you decide which genetic tests are right for you, explain what the results mean for your siblings or children, and discuss family planning options, privacy, and insurance implications [4][6].
  • Primary Care Physician (PCP): Your PCP remains vital for managing your overall health, including routine screenings and vaccinations, and coordinating care between different specialists [7].
  • Renal Dietitian: A specialist who can help you navigate salt restriction and other dietary changes while ensuring you stay well-nourished [7].
  • Transplant Team: If your kidney function is declining, you should be introduced to a transplant nephrologist and surgeon early (often when your eGFR is around 25-30) to discuss preemptive transplantation and independent evaluations of living donors [8][9].

Preparing for Your First Consultation

Specialized clinics often have long wait times. To make the most of your first visit, you should gather and bring the following medical records [10]:

  1. A Family Health Tree (Pedigree): Write down which relatives had kidney disease, high blood pressure, or went on dialysis. Include the ages they were diagnosed and any other health issues they had, such as gout or liver cysts [11][12].
  2. Imaging Reports and CDs: Don’t just bring the written report from an ultrasound or MRI; bring the actual images on a disc or digital drive. A specialized nephrologist may want to look at the cyst distribution or kidney volume themselves [13][14].
  3. Lab History (The “Trend”): Bring at least 2–3 years of your blood work (specifically creatinine and eGFR) and urine tests (UACR). One single data point is less helpful than seeing the “slope” of how your function has changed over time [10][15].
  4. Blood Pressure Logs: Bring a week’s worth of home blood pressure readings taken in a calm, resting state [16].
  5. Biopsy and Past Genetic Reports: If you have ever had a kidney biopsy or prior genetic testing, the full laboratory reports are essential—even if they were “negative” or “inconclusive” in the past [17][18].

Advocating for a Genetic Diagnosis

If your current diagnosis is still the descriptive “autosomal dominant progressive nephropathy,” you have the right to ask for a more specific answer. In the modern era, pursuing the exact gene mutation is a recommended step in care [11].

A precise name allows you to access clinical trials, qualify for specific medications like tolvaptan, and provides a clear testing path for your family members [19][20]. Note that a “Variant of Uncertain Significance” (VUS) should not be used by itself to diagnose relatives or decide if someone can donate a kidney. If your current clinic does not offer genetic testing or counseling, you can ask for a referral to a Center of Excellence or an academic medical center with a dedicated nephrogenetics program [1][2]. This proactive step is often the key to seeking the best long-term outcomes for you and your family [3].

Common questions in this guide

Which specialists should be part of my inherited kidney disease care team?
A nephrologist with expertise in inherited kidney disease usually coordinates care. A genetic counselor, primary care clinician, renal dietitian, and, when kidney function declines, a transplant nephrologist and surgeon may also be involved.
What should I bring to my first inherited kidney disease appointment?
Bring a family health history, actual imaging files and reports, two to three years of creatinine, kidney-function, and urine results, home blood-pressure readings, and any biopsy or genetic-testing reports. Keeping these records together helps the specialist see how kidney function has changed over time.
Why is genetic testing important in autosomal dominant nephropathy?
Identifying the responsible gene can give the condition a more precise name, guide eligibility for some treatments or clinical trials, and clarify which relatives may need evaluation. A genetic counselor can explain privacy, insurance, family planning, and what the results mean.
What does a variant of uncertain significance mean?
A variant of uncertain significance, or VUS, is a genetic finding whose health meaning is not yet clear. It should not be used by itself to diagnose a relative or determine whether someone can donate a kidney; discuss it with a genetic counselor or specialist.
When should I talk with a transplant team?
If kidney function is declining, ask about a transplant referral before dialysis is needed. Many teams begin discussions when eGFR, a measure of kidney filtering, is about 25–30, so living donors and preemptive transplantation can be evaluated early.
How can my family history help the kidney specialist?
Record relatives with kidney disease, high blood pressure, dialysis, gout, liver cysts, hearing loss, or brain aneurysms, along with the ages when problems began. This family health tree can help the care team choose genetic testing and assess which relatives may need evaluation.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Do you have a specific interest or sub-specialty in inherited or genetic kidney diseases?
  2. 2.How many patients with ADPKD or ADTKD do you currently manage in your practice?
  3. 3.Does your clinic have a dedicated genetic counselor, or do you work closely with a medical genetics department?
  4. 4.If we pursue genetic testing, will you be able to help me interpret 'variants of uncertain significance' (VUS)?
  5. 5.Can you coordinate with a transplant team early on if I have family members who are interested in being living donors?
  6. 6.Are you comfortable working with my primary care doctor to manage my blood pressure targets and 'sick day' protocols?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Genetic kidney disease in adults-the pathologists' perspective.

    Paterson AL, Chan MMY, Roufosse C

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026; (41(8)):1421-1428 doi:10.1093/ndt/gfag047.

    PMID: 41848274
  2. 2

    Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders.

    Mallett AJ, McCarthy HJ, Ho G, et al.

    Kidney international 2017; (92(6)):1493-1506 doi:10.1016/j.kint.2017.06.013.

    PMID: 28844315
  3. 3

    Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

    Kidney international 2022; (101(6)):1126-1141 doi:10.1016/j.kint.2022.03.019.

    PMID: 35460632
  4. 4

    Genetic Counseling in Kidney Disease: A Perspective.

    Stein Q, Westemeyer M, Darwish T, et al.

    Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.

    PMID: 37334143
  5. 5

    Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

    Knoers N, Antignac C, Bergmann C, et al.

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2022; (37(2)):239-254 doi:10.1093/ndt/gfab218.

    PMID: 34264297
  6. 6

    Overview of ADPKD in Pregnancy.

    Campbell RE, Edelstein CL, Chonchol M

    Kidney international reports 2025; (10(4)):1011-1019 doi:10.1016/j.ekir.2024.12.035.

    PMID: 40303224
  7. 7

    Detecting and managing the patient with chronic kidney disease in primary care: A review of the latest guidelines.

    Mayne KJ, Hanlon P, Lees JS

    Diabetes, obesity & metabolism 2024; (26 Suppl 6()):43-54 doi:10.1111/dom.15625.

    PMID: 38699995
  8. 8

    Evaluation for genetic disease in kidney transplant candidates: A practice resource.

    Ames EG, Anand PM, Bekheirnia MR, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2025; (25(2)):237-249 doi:10.1016/j.ajt.2024.10.019.

    PMID: 39488252
  9. 9

    The Diagnostic Yield of Genomic Sequencing-based Genetic Kidney Disease Testing in Kidney Transplant Candidates: Experience at an Urban US Transplant Center.

    Abu Al Rub F, Elsurer Afsar R, Fleetwood VA, et al.

    Transplantation 2025; (109(7)):1201-1208 doi:10.1097/TP.0000000000005288.

    PMID: 39819994
  10. 10

    Proteinuria-take a closer look!

    Bökenkamp A

    Pediatric nephrology (Berlin, Germany) 2020; (35(4)):533-541 doi:10.1007/s00467-019-04454-w.

    PMID: 31925536
  11. 11

    Autosomal Dominant Tubulointerstitial Kidney Disease.

    Bleyer AJ, Kidd K, Živná M, Kmoch S

    Advances in chronic kidney disease 2017; (24(2)):86-93 doi:10.1053/j.ackd.2016.11.012.

    PMID: 28284384
  12. 12

    Polycystic Kidney Disease without an Apparent Family History.

    Iliuta IA, Kalatharan V, Wang K, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(9)):2768-2776 doi:10.1681/ASN.2016090938.

    PMID: 28522688
  13. 13

    [Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease].

    Magistroni R, Izzi C, Scolari F

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 2016; (33(2)).

    PMID: 27067212
  14. 14

    Typical Clinical Presentation of an Autosomal Dominant Polycystic Kidney Disease Patient with an Atypical Genetic Pattern.

    Marzano N, Caprara C, Reis T, et al.

    Genes 2024; (16(1)) doi:10.3390/genes16010039.

    PMID: 39858586
  15. 15

    The Clinical Utility of Genetic Testing in the Diagnosis and Management of Adults with Chronic Kidney Disease.

    Dahl NK, Bloom MS, Chebib FT, et al.

    Journal of the American Society of Nephrology : JASN 2023; (34(12)):2039-2050 doi:10.1681/ASN.0000000000000249.

    PMID: 37794564
  16. 16

    Blood pressure control in patients with chronic kidney disease according to office and home blood pressures.

    Chantrel F, Ott J, Dimitrov Y, et al.

    Blood pressure monitoring 2020; (25(5)):246-251 doi:10.1097/MBP.0000000000000463.

    PMID: 32842021
  17. 17

    Utility of Genomic Testing after Renal Biopsy.

    Murray SL, Dorman A, Benson KA, et al.

    American journal of nephrology 2020; (51(1)):43-53 doi:10.1159/000504869.

    PMID: 31822006
  18. 18

    Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.

    Okada E, Morisada N, Horinouchi T, et al.

    Kidney international reports 2022; (7(4)):857-866 doi:10.1016/j.ekir.2021.12.037.

    PMID: 35497811
  19. 19

    Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025.

    Gordon CE, Garimella PS, Perrone RD, Miskulin DC

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2025; (86(4)):525-542 doi:10.1053/j.ajkd.2025.05.010.

    PMID: 40844441
  20. 20

    Genetic Testing and Counselling for Hereditary Renal Carcinoma: What Do Clinicians Need to Know?

    Re C, Pecoraro A, Stewart GD, et al.

    European urology open science 2025; (82()):131-141 doi:10.1016/j.euros.2025.10.009.

    PMID: 41280159

This page is for informational purposes only and does not constitute medical advice. Discuss genetic testing, blood pressure goals, medications, and transplant timing with your nephrologist and genetic counselor.

Get notified when new evidence is published on Autosomal dominant progressive nephropathy with hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.